Medtronic sells PDN (prostatic disc nucleus) device in Europe and India:
This article was originally published in Clinica
Executive Summary
Medtronic Sofamor Danek is to sell Raymedica's prostatic disc nucleus (PDN) in Europe and India and has made an undisclosed equity investment in the development-stage company. The PDN, which is for the treatment of low back pain for patients not responding to conservative care, is made of a hydrogel material that is designed to replace the function of a failed spinal disc nucleus. Medtronic has negotiation rights for further territories and will also collaborate with Raymedica on new instrumentation development. No further details are yet available.